The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

One of the standout products in Boston Scientific’s portfolio is the Watchman FLX Left Atrial Appendage Closure (LAAC) device. Recent clinical trial results from the OPTION study demonstrated ...

One of the standout products in Boston Scientific's portfolio is the Watchman FLX Left Atrial Appendage Closure (LAAC) device. Recent clinical trial results from the OPTION study demonstrated ...

Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc. (GS), The Progressive Corporation (PGR) and Boston Scientific Corporation (BSX), as ...

Strong worldwide demand for its MedSurg and Cardiovascular lines, traction in the United States and outside for its the next generation WATCHMAN FLX and FLX Pro, as well as contribution from ...

The Watchman FLX, a key product within the cardiovascular segment, has been a significant driver of sales growth. Additionally, the company's adjusted operating margin expanded from 25.6% in 2022 ...

It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices ...